RECURSION PHARMACEUTICALS, INC. — Form D

RECURSION PHARMACEUTICALS, INC. of SALT LAKE CITY, UT, a company, filed a Form D exempt-offering notice with the SEC on 2016-09-14. The offering totals $12.9M, of which $12.9M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (33)

Showing 25 of 33 people.

NameRoleLocation
DEAN Y LIDirectorSalt Lake City, UT
Christopher GibsonDirectorBrandon, FL
Christopher GibsonExecutive OfficerBrandon, FL
R. Martin ChavezDirectorDallas, TX
ROBERT C HERSHBERGDirectorSALT LAKE CITY, UT
MICHAEL MARTIN SECORAExecutive OfficerSALT LAKE CITY, UT
MICHAEL MARTIN SECORAPromoterSALT LAKE CITY, UT
DEAN C LIDirectorSALT LAKE CITY, UT
DEAN C LIExecutive OfficerSALT LAKE CITY, UT
DEAN C LIPromoterSALT LAKE CITY, UT
ZACHARY C BOGUEDirectorPALO ALTO, CA
ZAVAIN C DARDirectorMENLO PARK, CA
BLAKE C BORGESONDirectorSALT LAKE CITY, UT
BLAKE C BORGESONExecutive OfficerSALT LAKE CITY, UT
BLAKE C BORGESONPromoterSALT LAKE CITY, UT
TERRY-ANN C BURRELLDirectorSALT LAKE CITY, UT
H. PERRY FELLDirectorSALT LAKE CITY, UT
ZACHARY PERRY BOGUEDirectorPALO ALTO, CA
ZAVAIN PERRY DARDirectorMENLO PARK, CA
JOHN PERRY PEREIRAExecutive OfficerSALT LAKE CITY, UT
DEAN Y LIExecutive OfficerSalt Lake City, UT
DEAN Y LIPromoterSalt Lake City, UT
REID PERRY HUTCHINSDirectorGLENN FALLS, NY
Perry FellDirectorKirkland, WA
Blake BorgesonDirectorSalt Lake City, UT

Other filings by this issuer (11)

FiledFormOfferingSold
2020-11-12D/A$245.9M$245.9M
2020-09-15D$235.5M$235.5M
2019-08-13D$122.1M$122.1M
2017-10-06D$60.0M$55.8M
2016-12-02D/A$15.0M$15.0M
2016-09-14D$32.0M$32.0M
2016-09-14D$4.1M$4.1M
2015-12-04D$2.7M$2.6M
2015-02-23D$1.0M$830K
2014-04-02D$200K$80K
2014-04-02D/A$200K$80K

More